Sidoinnehåll
Räknare
Bedömning
Rekommendation för OAK ESC 20201
- Män:
- CHA₂DS₂-VASc-Score ≥ 2: OAK rekommenderas (ESC IA)
- CHA₂DS₂-VASc-Score =1 “should be considered” (ESC IIA), “considering individual characteristics and patient preferences”
- Kvinnor:
- CHA₂DS₂-VASc-Score ≥ 3: OAK rekommenderas (ESC IA)
- CHA₂DS₂-VASc-Score =2 “should be considered” (ESC IIA), “considering individual characteristics and patient preferences”
CHA₂DS₂-VASc-Score: Förklaring av riskfaktorer
CHA₂DS₂-VASc-Score2 ska användas (ESC IA indikation) för bedömning av stroke-risken och vid beslutsfattning om oral antikoagulation (OAK) hos patienter med förmaksflimmer.3
| Riskfaktor | Poäng | |
|---|---|---|
| C | Congestive heart failure Signs/symptoms of heart failure or objective evidence of reduced left ventricular ejection fraction | 1 |
| H | Hypertension Resting blood pressure >140/90 mmHg on at least two occasions or current antihypertensive treatment | 1 |
| A₂ | Age 75 years or older | 2 |
| D | Diabetes mellitus Fasting glucose >7 mmol/L or treatment with oral hypoglycaemic agent and/or insulin | 1 |
| S₂ | Previous stroke, transient ischaemic attack, or thromboembolism | 2 |
| V | Vascular disease Previous myocardial infarction, peripheral artery disease, or aortic plaque | 1 |
| A | Age 65–74 years | 1 |
| Sc | Sex category (female) | 1 |
ESC-tabell: detaljerat om riskfaktorer
ESC 2020: Tabell med detaljförklaring av varje riskfaktor: (klicka på dropdown)
Hur CHA₂DS₂-VASc-Score ska användas
Relaterad sida
Litteratur
ESC guideline förmaksflimmer 20201
ESC guidline förmaksflimmer 2016
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation2 (CHA₂DS₂-VASc-Score publikation)
Last Updated on July 4, 2024 by Christian Dworeck
har författat denna sidan
Latest posts by Christian Dworeck (see all)
- När ska vi gå till akut koronarangio efter hjärtstopp? Ny sida på kardiologi.se - April 16, 2025
- Föreläsning om MINOCA - January 26, 2025
- Ny sida om MINOCA (hjärtinfarkt utan signifikanta stenoser i kranskärlen) - November 1, 2024
- Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612. Erratum in: Eur Heart J. 2021 Feb 1;42(5):507. Erratum in: Eur Heart J. 2021 Feb 1;42(5):546-547. Erratum in: Eur Heart J. 2021 Feb 1;42(5):541-543. PMID: 32860505. [↩] [↩]
- Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010 Feb;137(2):263-72. doi: 10.1378/chest.09-1584. Epub 2009 Sep 17. PMID: 19762550. [↩] [↩]
- Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-2962. doi:10.1093/eurheartj/ehw210 [↩]
